Transitional Cell Carcinoma (TCC)
Transitional cell carcinoma (TCC) is one of the most common types of bladder cancer. It can also affect the kidneys and urinary accessory organs. Tumors grow in the tissue on the inner surfaces of these organs. It is believed that chronic inflammation from catheters, bladder stones, and infections can lead to the development of this cancer. Like all forms of bladder cancer, it is exceptionally difficult to treat.
Unfortunately, the diabetes medication Actos has been linked to incidences of bladder cancer. If you or someone you love has been diagnosed with bladder cancer after taking Actos, you may be eligible for financial compensation. To learn more about how an Actos lawsuit can help you receive the restitution you need, contact the attorneys of Williams Kherkher at 800-641-9810.
The following are some informative statistics about transitional cell carcinoma and bladder cancer:
- 90% of bladder cancers in North and South America, Europe, and Asia are TCC
- 55 – 60% of the cases are low-grade and noninvasive
- 30 – 40% of patients have multiple tumors at the time of diagnosis
- In the majority of TCC patients, the cancer will progress or recur rather than successfully disappear
If you have developed bladder cancer after taking Actos, you shouldn’t have to cope with this tragic situation by yourself.
At Williams Kherkher, we believe that the manufacturers of drugs should be held accountable for the harm that their products cause. If you have taken Actos and have been diagnosed with bladder cancer, it may be in your best interest to pursue legal action. You may be able to receive financial compensation for your medical expenses and emotional trauma. Call us today at 800-641-9810 to speak with an experienced Actos attorney about your legal rights and options.